Article Contents

1. Quick comparison
2. What Adamax is
3. 850–856 Da category
4. 984 Da intermediate version
5. 1032 Da “true” version
6. Interpreting mass differences
7. HPLC compared with MS
8. For example, How to evaluate a COA
9. Common labeling problems
10. Frequently asked questions

Adamax Versions Comparison: Quick Reference

What Is Adamax?

Likewise, Adamax is a nonstandardized research name used for a modified peptide concept related to Semax and, in many supplier descriptions, an adamantane-containing or adamantyl-modified derivative.

Semax itself is the heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro, often written MEHFPGP. The published Semax literature includes studies of neurotrophin expression, BDNF/TrkB signaling, oxidative stress, metal binding and experimental neuroprotection. However, those findings belong to Semax. They should not automatically be transferred to Adamax, because changing an N-terminus, a C-terminus or adding a bulky lipophilic group can alter charge, conformation, solubility, receptor interactions, metabolism and analytical behavior.

Furthermore, the word Adamax is not controlled by the United States Pharmacopeia, European Pharmacopoeia or another widely recognized compendium. Different manufacturers may use the same name for materials with different terminal groups, linkers, counterions or molecular weights. Consequently, the name on a vial is only a starting claim. The definitive description should include a written structure, expected formula, theoretical mass, observed mass, chromatographic method and lot-specific raw data.

Version 1: Approximately 850–856 Da, Often Called N-Acetyl

The first category is often shortened to “850 Adamax.” Chemically, however, a mass in this region is much more consistent with an N-acetylated Semax-like peptide than with the higher-mass Adamax categories.

Why the number is often rounded to 850

Published databases place Semax around 813.9 Da by average molecular mass. Adding an acetyl group to the free N-terminal amino group produces a net mass increase of approximately 42.01 Da. A simple average-mass estimate therefore falls close to 855.9 Da. Depending on whether a supplier reports average neutral mass, monoisotopic mass, a rounded nominal value, an ion, a salt or an incorrectly transcribed specification, the material may be informally described as “850,” “855” or “856.”

What N-terminal acetylation changes

N-terminal acetylation caps the peptide’s free alpha-amino group. This removes a site that would otherwise carry charge under many conditions and can change metal coordination, enzymatic susceptibility, chromatographic retention and biological interactions. A Semax-specific study showed that N-terminal acetylation changed copper and zinc coordination as well as measured biological properties. Nevertheless, acetylation does not universally guarantee greater stability or a particular biological effect; the result is sequence- and assay-dependent.

Why “850 Adamax” can be misleading

However, If an 850–856 Da product contains only an acetylated Semax backbone and no adamantane-derived modification, calling it Adamax may blur a meaningful structural distinction. A responsible listing should state the actual sequence and terminal groups rather than relying on a brand-like name. At minimum, researchers should request the expected molecular formula and an intact-mass spectrum.

Version 2: 984 Da Adamax

Therefore, The second category is Adamax 984 Da. This is the corrected middle value and is commonly discussed as an intermediate, regular or less extensively modified Adamax form.

Unlike Semax, the 984 Da Adamax structure is not established in a major public compound database with one authoritative formula and sequence. Therefore, 984 Da should be treated as an analytical target associated with a supplier-defined structure—not as a complete structural description by itself.

What 984 Da may indicate

Importantly, In commercial discussions, 984 Da is often represented as a modified Semax-derived scaffold containing part of the chemistry associated with Adamax but lacking one or more features attributed to the 1032 Da version. Which feature is absent cannot be determined reliably from the mass difference alone. The difference could involve terminal capping, a linker, a particular adamantane-related substituent, counterion handling, an alternate synthetic building block or simply inconsistent reporting.

Why 984 Da is not automatically “fake”

First, A 984 Da target may be a legitimate, intentionally synthesized compound when the supplier clearly defines it and the analytical results match that definition. The problem arises when a 984 Da material is sold as chemically identical to a 1032 Da target without disclosure. Two materials separated by roughly 48 Da are not the same neutral molecular species merely because both are marketed under the same name.

What documentation should accompany 984 Da material

• ✓Next, Complete written structure or unambiguous sequence/modification notation
• ✓Moreover, Theoretical average and monoisotopic neutral masses
• ✓In addition, Expected principal ions and charge states
• ✓Observed deconvoluted intact mass
• ✓Therefore, LC-MS chromatogram linked to the same sample
• ✓Likewise, Lot number matching the vial and COA
• ✓However, Purity calculation with integration details
• ✓First, Explanation of salt, counterion and water content

Version 3: 1032 Da “True” Adamax

Next, The third category is the approximately 1032 Da Adamax target. Some suppliers call this “true Adamax,” “fully modified Adamax,” “N-acetyl Adamax amidate” or a similar phrase. These labels are not fully interchangeable unless the underlying structure is disclosed.

Why 1032 Da receives the “true” label

The “true” distinction is generally intended to communicate that the material contains the complete set of modifications expected by that supplier’s Adamax specification. In other words, the label distinguishes the 1032 Da target from lower-mass Semax-like or intermediate products. Nevertheless, the phrase remains a marketplace convention. It is not an official chemical name, and it does not replace structural evidence.

The 48 Da difference matters

In addition, A nominal 1032 Da compound is approximately 48 Da heavier than a nominal 984 Da compound. That gap is too large to dismiss as ordinary instrument error. Modern, properly calibrated high-resolution mass spectrometry should distinguish these targets easily. At the same time, a 48 Da difference does not uniquely identify a specific modification; multiple combinations of elemental changes can produce similar nominal shifts.

What “fully modified” should mean analytically

However, A strong identity package should do more than show one peak near an expected number. It should connect the proposed structure to the observed intact mass and, when practical, to diagnostic fragment ions. Orthogonal methods—such as amino-acid analysis, nuclear magnetic resonance for a small-molecule modifier, or targeted chemical assays—may provide additional confidence when a novel noncanonical group is involved.

Why Molecular Weight Alone Does Not Reveal the Full Structure

Therefore, A molecular mass is a powerful constraint, but it is not a complete molecular identity. Isomers, positional isomers and different modification sites may share the same elemental composition and exact mass. Conversely, the same core compound can appear under different reported values because of salts, adducts, isotopes, charge states or inconsistent calculation conventions.

First, For Adamax versions, the COA should state exactly which convention is being used. A bare number such as “1032.24” without formula, ion notation, charge assignment or spectrum is incomplete.

HPLC vs Mass Spectrometry for Adamax Identity

What HPLC can establish

Reversed-phase HPLC separates components according to their interactions with the stationary phase and mobile phase. A dominant peak can support a high relative purity claim under the stated detection conditions. HPLC can also reveal multiple peaks, degradation products or major synthesis impurities.

What HPLC cannot establish by itself

Retention time is not a unique molecular fingerprint. Different compounds may co-elute or have similar retention. A clean chromatogram can therefore represent a highly pure wrong compound. This limitation is especially important when distinguishing 984 from 1032 Da material.

What MS contributes

Mass spectrometry measures mass-to-charge ratios. After charge-state assignment and deconvolution, intact-mass analysis can determine whether the major component is consistent with an 850–856, 984 or 1032 Da target. Tandem MS can then fragment the molecule and provide evidence for the peptide sequence and the location of modifications.

How to Evaluate an Adamax Certificate of Analysis

First, A credible COA should permit the receiving laboratory to connect the vial, sample, method and results. Decorative formatting is less important than traceability and raw analytical evidence.

• ✓In addition, Product name plus explicit structural notation
• ✓However, Unique batch or lot number
• ✓Manufacture or test date
• ✓Therefore, Expected formula and theoretical mass
• ✓Likewise, Observed intact mass with tolerance
• ✓Ion and charge-state assignments
• ✓For example, Raw or high-resolution mass spectrum
• ✓Moreover, HPLC chromatogram and integration table
• ✓Next, Column, mobile phases, gradient and detector wavelength
• ✓In addition, Reference standard or identity strategy
• ✓However, Testing laboratory and authorized reviewer
• ✓Clear pass/fail specifications

Red flags

• Therefore, The same generic spectrum appears on multiple unrelated lots.
• Likewise, The HPLC report lists purity but no identity test.
• Importantly, The COA says 1032 Da while the dominant deconvoluted mass is near 984 Da.
• First, The report supplies only a cropped peak image with no axis labels.
• Next, The lot number on the COA does not match the vial.
• Moreover, the product may be called “N-acetyl” without identifying which nitrogen carries the acetyl group.
• In addition, a report may present a sodium or potassium adduct as the neutral mass.

Common Adamax Labeling and Interpretation Errors

1. Treating 850, 984 and 1032 as potency grades

However, The numbers describe nominal molecular-mass categories, not strength, purity or potency. A higher molecular weight does not automatically mean a stronger or better product.

2. Calling every acetylated Semax derivative Adamax

Therefore, N-acetylation is one defined chemical change. Adamax descriptions commonly imply additional noncanonical chemistry. The terms should not be collapsed without structural documentation.

3. Calling 984 Da counterfeit solely because it is not 1032 Da

Likewise, A disclosed 984 Da compound may be a valid research target. The concern is substitution or ambiguous labeling, not the mere existence of a lower-mass version.

4. Assuming 1032 Da proves the modification site

Importantly, An intact mass near 1032 supports elemental consistency but may not locate the modification. Fragmentation or another orthogonal method is needed for stronger site-specific evidence.

5. Using HPLC purity as proof of molecular identity

First, A 99% area-purity result means the primary UV-detected component dominated that chromatographic method. It does not establish that the component was Adamax, nor whether it was the 984 or 1032 Da version.

Research Interpretation: What Can and Cannot Be Claimed

Frequently Asked Questions About Adamax Versions

Identity, Mass, and Analytical Questions

Modification and Verification Questions

Adamax Versions Comparison: Final Laboratory Guidance

In conclusion, the three commonly discussed Adamax versions should not be treated as interchangeable. First, the approximately 850–856 Da category is most consistent with N-acetylated Semax-like chemistry. Next, the 984 Da category represents a supplier-defined intermediate or less extensively modified Adamax target. Finally, the 1032 Da category is frequently marketed as fully modified or “true” Adamax, but that label is not an official chemical standard.

Therefore, researchers should evaluate each lot by its disclosed structure and analytical evidence. HPLC addresses chromatographic purity, whereas intact mass spectrometry distinguishes the major molecular-weight categories. When the location of a modification matters, tandem MS or another orthogonal identity method should be added.

Most importantly, claims derived from published Semax studies or general adamantane medicinal chemistry should not be presented as direct evidence for Adamax. Until compound-specific, peer-reviewed data and a standardized identity become available, transparent nomenclature and rigorous per-lot characterization are essential.